- Report
- March 2024
- 189 Pages
Global
From €3257EUR$3,374USD£2,794GBP
€3619EUR$3,749USD£3,104GBP
- Report
- September 2023
- 129 Pages
Global
From €5743EUR$5,950USD£4,926GBP
- Report
- April 2024
- 335 Pages
Global
From €5405EUR$5,600USD£4,637GBP
- Report
- April 2024
- 136 Pages
Global
From €3763EUR$3,899USD£3,228GBP
- Report
- October 2023
- 190 Pages
Global
From €4729EUR$4,900USD£4,057GBP
- Report
- February 2024
- 250 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- January 2024
- 175 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- November 2023
- 175 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1206EUR$1,250USD£1,035GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1206EUR$1,250USD£1,035GBP
- Drug Pipelines
- April 2024
- 80 Pages
Global
From €1448EUR$1,500USD£1,242GBP
- Report
- October 2023
- 175 Pages
Global
From €4729EUR$4,900USD£4,057GBP
- Report
- April 2024
- 175 Pages
From €4826EUR$5,000USD£4,140GBP
- Report
- April 2023
- 115 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- March 2021
- 120 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- January 2022
- 70 Pages
Global
From €965EUR$1,000USD£828GBP
- Report
- March 2022
- 120 Pages
Global
From €2413EUR$2,500USD£2,070GBP
- Report
- February 2020
- 231 Pages
Global
From €3475EUR$3,600USD£2,981GBP
- Report
- February 2020
- 94 Pages
Europe
From €1448EUR$1,500USD£1,242GBP
- Report
- February 2020
- 94 Pages
Asia Pacific
From €1448EUR$1,500USD£1,242GBP
The Human Growth Hormone (HGH) market is a segment of the Endocrine and Metabolic Disorders Drugs market. HGH is a hormone produced by the pituitary gland that is responsible for growth and development in humans. It is used to treat a variety of conditions, including growth hormone deficiency, Turner syndrome, Prader-Willi syndrome, and chronic kidney disease. HGH is also used to improve athletic performance and to treat age-related conditions such as osteoporosis and muscle wasting.
HGH is available in both injectable and oral forms, and is typically prescribed by endocrinologists. The market for HGH is expected to grow due to the increasing prevalence of endocrine and metabolic disorders, as well as the growing demand for performance-enhancing drugs.
Some of the major companies in the HGH market include Pfizer, Novo Nordisk, Eli Lilly, Merck, and Sanofi. Show Less Read more